{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:01:34Z","timestamp":1790654494319,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bbi.2023.09.004","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T17:20:07Z","timestamp":1694107207000},"page":"299-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study"],"prefix":"10.1016","volume":"114","author":[{"given":"N.L.","family":"Mason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P.C.","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Mallaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"de la Torre Fornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Reckweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.H.Y.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.R.P.W.","family":"Hutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Feilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Ramaekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2023.09.004_b0005","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.bbi.2020.02.008","article-title":"Decreased IL-1\u03b2-induced CCL20 response in human iPSC-astrocytes in schizophrenia: Potential attenuating effects on recruitment of regulatory T cells","volume":"87","author":"Akkouh","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.09.004_b0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.12688\/wellcomeopenres.15191.1","article-title":"Raincloud plots: a multi-platform tool for robust data visualization","volume":"4","author":"Allen","year":"2019","journal-title":"Wellcome open research"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1600001","article-title":"The role of corticotropin-releasing factor in depression and anxiety disorders","volume":"160","author":"Arborelius","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbi.2023.09.004_b0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neulet.2016.11.064","article-title":"Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies","volume":"649","author":"Averill","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.bbi.2023.09.004_b0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000049028","article-title":"Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder","volume":"9","author":"Baker","year":"2001","journal-title":"Neuroimmunomodulation"},{"issue":"4","key":"10.1016\/j.bbi.2023.09.004_b0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/2045125314527985","article-title":"Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles","volume":"4","author":"Baumeister","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"issue":"9","key":"10.1016\/j.bbi.2023.09.004_b0035","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","article-title":"Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?","volume":"233","author":"Baumeister","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2023.09.004_b0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fimmu.2014.00136","article-title":"The HPA - immune axis and the immunomodulatory actions of glucocorticoids in the brain","volume":"5","author":"Bellavance","year":"2014","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.bbi.2023.09.004_b0045","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1113\/JP271539","article-title":"Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation","volume":"594","author":"Bonaz","year":"2016","journal-title":"J. Physiol."},{"issue":"15","key":"10.1016\/j.bbi.2023.09.004_b0050","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1 Pt 2","key":"10.1016\/j.bbi.2023.09.004_b0055","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0090-1229(92)90035-M","article-title":"Inflammatory cytokines","volume":"62","author":"Cerami","year":"1992","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.2018.66","article-title":"Treatment-resistant depression and peripheral C-reactive protein","volume":"214","author":"Chamberlain","year":"2019","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2023.09.004_b0065","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11481-013-9460-x","article-title":"Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain","volume":"8","author":"Chang","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2023.09.004_b0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.psyneuen.2017.01.035","article-title":"HPA-axis and inflammatory reactivity to acute stress is related with basal HPA-axis activity","volume":"78","author":"Chen","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.bbi.2023.09.004_b0075","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","article-title":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","volume":"47","author":"D\u2019Souza","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jaci.2018.12.755","article-title":"Cytokine, sickness behavior, and depression","volume":"29","author":"Dantzer","year":"2009","journal-title":"Immunology and Allergy Clinics"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2023.09.004_b0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2023.09.004_b0100","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2023.09.004_b0105","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41573-021-00368-1","article-title":"Immune targets for therapeutic development in depression: towards precision medicine","volume":"21","author":"Drevets","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bbi.2023.09.004_b0110","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bbi.2009.12.009","article-title":"Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood","volume":"24","author":"Eisenberger","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.09.004_b0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbi.2012.05.006","article-title":"Depressive symptoms enhance stress-induced inflammatory responses","volume":"31","author":"Fagundes","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.bbi.2023.09.004_b0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2023.09.004_b0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02900219","article-title":"Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission","volume":"247","author":"Frommberger","year":"1997","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.bbi.2023.09.004_b0130","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/0269881120936486","article-title":"Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca","volume":"34","author":"Galv\u00e3o-Coelho","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.bbi.2023.09.004_b0135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.bbi.2023.09.004_b0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3041","article-title":"The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease","volume":"11","author":"Gleeson","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bbi.2023.09.004_b0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.bbi.2023.09.004_b0150","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbi.2023.09.004_b0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/7854_2016_40","article-title":"Inflammation effects on brain glutamate in depression: mechanistic considerations and treatment implications","author":"Haroon","year":"2016","journal-title":"Inflammation-associated depression: Evidence, mechanisms and implications"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: a trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","article-title":"Biological basis of the behavior of sick animals","volume":"12","author":"Hart","year":"1988","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose\u2013effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2023.09.004_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ynstr.2016.03.003","article-title":"Integrating Interleukin-6 into depression diagnosis and treatment","volume":"4","author":"Hodes","year":"2016","journal-title":"Neurobiol. Stress"},{"issue":"4","key":"10.1016\/j.bbi.2023.09.004_b0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/pcn.12820","article-title":"Inflammation and post-traumatic stress disorder","volume":"73","author":"Hori","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0185","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mp.2016.167","article-title":"Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions","volume":"23","author":"Kappelmann","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jamapsychiatry.2020.3436","article-title":"Dissecting the association between inflammation, metabolic dysregulation, and specific depressive symptoms: a genetic correlation and 2-sample mendelian randomization study","volume":"78","author":"Kappelmann","year":"2021","journal-title":"JAMA Psychiat."},{"issue":"04","key":"10.1016\/j.bbi.2023.09.004_b0195","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S1461145709009924","article-title":"A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder","volume":"12","author":"Khairova","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2023.09.004_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.721537","article-title":"Persisting effects of ayahuasca on empathy, creative thinking, decentering, personality, and well-being","volume":"12","author":"Kiraga","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2023.09.004_b0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mehy.2019.02.029","article-title":"Psychedelic medicine: The biology underlying the persisting psychedelic effects","volume":"125","author":"Kuypers","year":"2019","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbi.2023.09.004_b0210","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3389\/fimmu.2019.01696","article-title":"The role of inflammation in depression and fatigue","volume":"10","author":"Lee","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2023.09.004_b0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5483\/BMBRep.2015.48.4.275","article-title":"Technical and clinical aspects of cortisol as a biochemical marker of chronic stress","volume":"48","author":"Lee","year":"2015","journal-title":"BMB Rep."},{"issue":"11","key":"10.1016\/j.bbi.2023.09.004_b0220","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0006-3223(99)00266-8","article-title":"Neural circuits mediating stress","volume":"46","author":"L\u00f3pez","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2023.09.004_b0225","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1073\/pnas.0337481100","article-title":"Course of illness, hippocampal function, and hippocampal volume in major depression","volume":"100","author":"MacQueen","year":"2003","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0230","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-10-66","article-title":"Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways","volume":"10","author":"Maes","year":"2012","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbi.2006.10.008","article-title":"Endocrinology: the active partner in PNI research","volume":"21","author":"Malarkey","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.09.004_b0240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbi.2017.01.013","article-title":"Systemic inflammation and resting state connectivity of the default mode network","volume":"62","author":"Marsland","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.09.004_b0245","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2018.02.011","article-title":"Circulating cytokine levels are associated with symptoms of depression and anxiety among people with alcohol and drug use disorders","volume":"318","author":"Martinez","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/02791072.2019.1580804","article-title":"Sub-acute effects of psilocybin on empathy, creative thinking, and subjective well-being","volume":"51","author":"Mason","year":"2019","journal-title":"J. Psychoact. Drugs"},{"issue":"12","key":"10.1016\/j.bbi.2023.09.004_b0255","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01335-5","article-title":"Spontaneous and deliberate creative cognition during and after psilocybin exposure","volume":"11","author":"Mason","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0265","doi-asserted-by":"crossref","DOI":"10.3402\/ejpt.v4i0.19854","article-title":"Acute stress differentially affects spatial configuration learning in high and low cortisol-responding healthy adults","volume":"4","author":"Meyer","year":"2013","journal-title":"Eur. J. Psychotraumatol."},{"issue":"9","key":"10.1016\/j.bbi.2023.09.004_b0270","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2023.09.004_b0280","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.4049\/jimmunol.166.6.4042","article-title":"Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during <em>Escherichia coli<\/em> pneumonia in mice","volume":"166","author":"Mizgerd","year":"2001","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bbi.2023.09.004_b0285","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/npp.2015.17","article-title":"Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression","volume":"40","author":"Moieni","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.bbi.2023.09.004_b0290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/15622970701263303","article-title":"Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression","volume":"8","author":"M\u00f6ssner","year":"2007","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.004_b0295","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1742-2094-10-43","article-title":"Neuroinflammation and psychiatric illness","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2023.09.004_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113245","article-title":"N, N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats","volume":"327","author":"Nardai","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2023.09.004_b0305","doi-asserted-by":"crossref","unstructured":"Nau Jr, F., et al., Serotonin 5-HT2A receptor activation blocks TNF-\u03b1 mediated inflammation in vivo. PloS one, 2013. 8(10): p. e75426.","DOI":"10.1371\/journal.pone.0075426"},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0310","doi-asserted-by":"crossref","first-page":"L191","DOI":"10.1152\/ajplung.00138.2013","article-title":"Serotonin 5-HT2 receptor activation prevents allergic asthma in a mouse model","volume":"308","author":"Nau","year":"2015","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2023.09.004_b0320","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.biopsycho.2014.03.009","article-title":"Interleukin-6 and soluble interleukin-6 receptor levels in posttraumatic stress disorder: associations with lifetime diagnostic status and psychological context","volume":"99","author":"Newton","year":"2014","journal-title":"Biol. Psychol."},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0325","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2023.09.004_b0330","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"12","key":"10.1016\/j.bbi.2023.09.004_b0335","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.bbi.2023.09.004_b0340","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2023.09.004_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.590095","article-title":"Proinflammatory cytokines predict brain metabolite concentrations in the anterior cingulate cortex of patients with bipolar disorder","volume":"11","author":"Poletti","year":"2020","journal-title":"Frontiers Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2023.09.004_b0350","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"J. Am. Med. Assoc."},{"issue":"881","key":"10.1016\/j.bbi.2023.09.004_b0355","article-title":"Modulation of social cognition via hallucinogens and \u201centactogens\u201d","volume":"10","author":"Preller","year":"2019","journal-title":"Frontiers Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2023.09.004_b0360","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1016\/j.psyneuen.2013.09.002","article-title":"Time dependent effects of stress prior to encoding on event-related potentials and 24 h delayed retrieval","volume":"38","author":"Quaedflieg","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"10.1016\/j.bbi.2023.09.004_b0365","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1016\/j.psyneuen.2013.09.002","article-title":"Time dependent effects of stress prior to encoding on event-related potentials and 24h delayed retrieval","volume":"38","author":"Quaedflieg","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2023.09.004_b0370","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.psyneuen.2016.12.009","article-title":"Examining habituation and sensitization across repetitive laboratory stress inductions using the MAST","volume":"77","author":"Quaedflieg","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0375","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"5","key":"10.1016\/j.bbi.2023.09.004_b0380","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2023.09.004_b0385","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2023.09.004_b0390","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41380-022-01924-w","article-title":"Inflammation and cognition in severe mental illness: patterns of covariation and subgroups","volume":"28","author":"S\u00e6ther","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2023.09.004_b0395","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ijnp\/pyx036","article-title":"Assessing the psychedelic \u201cafter-glow\u201d in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities","volume":"20","author":"Sampedro","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0400","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00213-017-4733-3","article-title":"Long-lasting subjective effects of LSD in normal subjects","volume":"235","author":"Schmid","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2023.09.004_b0405","doi-asserted-by":"crossref","unstructured":"Sharpley, C.F., Neurobiological Pathways between Chronic Stress and Depression: Dysregulated Adaptive Mechanisms? Clinical Medicine Insights: Psychiatry, 2009. 2: p. CMPsy.S3658.","DOI":"10.4137\/CMPsy.S3658"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0410","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1207\/s15327752jpa8401_09","article-title":"Conducting and interpreting canonical correlation analysis in personality research: a user-friendly primer","volume":"84","author":"Sherry","year":"2005","journal-title":"J. Pers. Assess."},{"key":"10.1016\/j.bbi.2023.09.004_b0415","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2017.00567","article-title":"The maastricht acute stress test (MAST): physiological and subjective responses in anticipation, and post-stress","volume":"8","author":"Shilton","year":"2017","journal-title":"Front. Psychol."},{"issue":"12","key":"10.1016\/j.bbi.2023.09.004_b0420","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.psyneuen.2012.04.012","article-title":"Introducing the Maastricht Acute Stress Test (MAST): a quick and non-invasive approach to elicit robust autonomic and glucocorticoid stress responses","volume":"37","author":"Smeets","year":"2012","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.bbi.2023.09.004_b0425","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: A meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2023.09.004_b0430","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and immunomodulation: novel approaches and therapeutic opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2023.09.004_b0435","doi-asserted-by":"crossref","unstructured":"Szabo, A., et al., Psychedelic N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells. PloS one, 2014. 9(8): p. e106533.","DOI":"10.1371\/journal.pone.0106533"},{"issue":"4","key":"10.1016\/j.bbi.2023.09.004_b0440","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1573395509666131203225659","article-title":"The brain-immune-gut triangle: innate immunity in psychiatric and neurological disorders","volume":"9","author":"Szabo","year":"2013","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.bbi.2023.09.004_b0445","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fpsyt.2020.00443","article-title":"Pharmacological treatment of anxiety disorders: the role of the HPA axis","volume":"11","author":"Tafet","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.bbi.2023.09.004_b0450","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2020.10.001","article-title":"Psychedelics as a novel approach to treating autoimmune conditions","volume":"228","author":"Thompson","year":"2020","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.bbi.2023.09.004_b0455","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.3390\/ijms21062194","article-title":"Role of interleukin-6 in depressive disorder","volume":"21","author":"Ting","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbi.2023.09.004_b0460","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrn2647","article-title":"Neural regulation of endocrine and autonomic stress responses","volume":"10","author":"Ulrich-Lai","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2023.09.004_b0465","first-page":"1","article-title":"Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution","author":"Uthaug","year":"2018","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.bbi.2023.09.004_b0470","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00213-019-05236-w","volume":"236","author":"Uthaug","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.bbi.2023.09.004_b0475","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00213-019-05414-w","article-title":"Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment","volume":"237","author":"Uthaug","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2023.09.004_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104793","article-title":"Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review","volume":"140","author":"van Elk","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.bbi.2023.09.004_b0485","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1177\/02698811211044679","article-title":"Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour","volume":"35","author":"van Ruitenbeek","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.bbi.2023.09.004_b0490","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2023.09.004_b0495","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0022167817709585","article-title":"Patients\u2019 accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression","volume":"57","author":"Watts","year":"2017","journal-title":"J. Humanist. Psychol."},{"issue":"2","key":"10.1016\/j.bbi.2023.09.004_b0500","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"Elevated C-reactive protein levels, psychological distress, and depression in 73 131 individuals","volume":"70","author":"Wium-Andersen","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.bbi.2023.09.004_b0505","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2004.11.014","article-title":"TNF\u03b1 potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF\u03baB inhibition","volume":"1034","author":"Zou","year":"2005","journal-title":"Brain Res."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123002684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123002684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:24:51Z","timestamp":1760171091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159123002684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":101,"alternative-id":["S0889159123002684"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2023.09.004","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2023.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}